Carglumic Acid [1188-38-1]

TargetMol Chemicals

Carglumic Acid

4

1188-38-1

Chemical

Research Use Only

Carglumic Acid

99.80%

C6H10N2O5

190.15

Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.

3 years

[C@@H](CCC(O)=O)(NC(N)=O)C(O)=O

-20°C

12352200